ibspot

ibspot Initiates Class II Recall for Unapproved Taoscare Motion Sickness Patches: Critical Regulatory Compliance Failure

ibspot has initiated a Class II recall for Taoscare Motion Sickness Patches due to marketing without an approved NDA/ANDA. This regulatory non-compliance, involving products manufactured by Henan Xinyongtal Medical Technology, highlights critical risks for distributors and procurement. Businesses must verify supplier regulatory approvals to avoid supply chain disruptions and legal liabilities associated with unapproved drug products.